Freemont Management S.A. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 5,000 shares of the medical equipment provider’s stock, valued at approximately $2,832,000.
Several other institutional investors also recently modified their holdings of the business. SFE Investment Counsel bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $336,000. Proactive Wealth Strategies LLC increased its stake in shares of Intuitive Surgical by 12.4% in the 4th quarter. Proactive Wealth Strategies LLC now owns 1,087 shares of the medical equipment provider’s stock worth $616,000 after acquiring an additional 120 shares in the last quarter. Atria Investments Inc increased its stake in shares of Intuitive Surgical by 21.8% in the 4th quarter. Atria Investments Inc now owns 35,939 shares of the medical equipment provider’s stock worth $20,354,000 after acquiring an additional 6,440 shares in the last quarter. Catalyst Financial Partners LLC increased its stake in shares of Intuitive Surgical by 10.3% in the 4th quarter. Catalyst Financial Partners LLC now owns 2,403 shares of the medical equipment provider’s stock worth $1,361,000 after acquiring an additional 225 shares in the last quarter. Finally, Strategic Family Wealth Counselors L.L.C. bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $285,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Performance
NASDAQ:ISRG opened at $432.27 on Thursday. The firm has a market cap of $153.09 billion, a P/E ratio of 52.40, a P/E/G ratio of 3.45 and a beta of 1.51. Intuitive Surgical, Inc. has a fifty-two week low of $417.74 and a fifty-two week high of $603.88. The firm has a 50-day simple moving average of $466.62 and a two-hundred day simple moving average of $515.53.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. Mizuho set a $525.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Monday, April 13th. UBS Group reduced their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research note on Tuesday, March 17th. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. The Goldman Sachs Group raised their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Finally, HSBC reduced their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $581.91.
Read Our Latest Report on Intuitive Surgical
Insider Activity
In other news, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 5,647 shares of company stock worth $2,760,359. 0.60% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
